HCG (Human Chorionic Gonadotropin) – Comprehensive Research Overview (2026)
HCG (Human Chorionic Gonadotropin) is a glycoprotein hormone produced during pregnancy and structurally similar to LH (luteinizing hormone). It is FDA-approved for ovulation induction, hypogonadism, and cryptorchidism. In research and clinical practice, HCG is widely used to stimulate endogenous testosterone production, maintain testicular function during TRT, support fertility, and as a post-cycle therapy (PCT) agent. It acts directly on Leydig cells in the testes, mimicking LH.
→ View HCG (for laboratory research use only)
Mechanism of Action
- Binds LH/hCG receptors on testicular Leydig cells, stimulating testosterone synthesis.
- Maintains intratesticular testosterone levels and testicular volume during exogenous androgen use.
- Stimulates ovarian follicle maturation and ovulation in women (via LH receptor).
- Supports Sertoli cell function and spermatogenesis.
Clinical Evidence and Research Findings
HCG has decades of clinical use with robust evidence for hypogonadism, fertility, and cryptorchidism. In men on TRT, HCG co-administration maintains testicular size, intratesticular testosterone, and fertility. It is a cornerstone of male fertility preservation protocols. FDA-approved formulations (Pregnyl, Novarel) are widely available.
→ Interested in researching HCG? View Product Options
Benefits (Research & Clinical Observations)
- Stimulation of endogenous testosterone production
- Maintenance of testicular volume and function during TRT
- Fertility preservation and spermatogenesis support
- Ovulation induction in women
- Post-cycle HPG axis recovery support
Typical Dosing Protocols
- Hypogonadism / TRT co-administration: 250–1,000 IU subcutaneous 2–3× per week
- Fertility (men): 1,000–2,000 IU 3× per week
- PCT: 500–1,000 IU every other day for 2–4 weeks
Safety Profile and Side Effects
Well-characterized safety profile from decades of clinical use. Common side effects: injection-site reactions, fluid retention, gynecomastia risk at high doses (via aromatization). Contraindicated in hormone-sensitive cancers.
Summary
HCG is an FDA-approved gonadotropin with extensive clinical evidence for testosterone stimulation, fertility support, and HPG axis maintenance. It remains a cornerstone of male hormone optimization and fertility research. As with all compounds in this library, off-label use should only be considered under qualified medical supervision.
For Laboratory Research Use View HCG →
Disclaimer This overview is strictly educational and based on publicly available scientific literature as of April 2026. It does not constitute medical advice. Always consult a qualified healthcare professional and comply with all applicable laws and regulations.